Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 600-734-7 | CAS number: 106276-78-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
The test item was tested for its mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains, i.e.
Salmonella typhimurium and Escherichia coli, in a reverse mutation assay including prival modification at concentrations of 33 μg - 5 000 μg/plate (SPT) and 33 μg - 5 000 μg/plate (Prival) in presence and absence of a metabolic activation system (liver S9 mix from induced rats and uninduced hamster). Precipitation of the test substance was found from about 33 μg/plate onward with and without S9 mix. A weak bacteriotoxic effect was occasionally observed depending on the strain and test conditions from about 1 000 μg/plate onward. A biologically relevant increase in the number of his+ or trp+ revertants was not observed in the standard plate test or in the prival preincubation test either without S9 mix or after the addition of a metabolizing system.
In a second non-prival Ames test the test substance was tested for mutagenic effects on histidine-auxotrophic mutants of Salmonella typhimurium (strain TA 98, TA 100, TA 1535 and TA 1537). The investigations were performed with the following concentrations of the test substance: 25, 75, 225, 675 and 2025 µg/0.1 mL, with and without microsomal activation (Aroclor 1254 induced rat liver S9 mix). At the following concentrations 75, 225, 675, 2025 µg/0.1 mL, with and without metabolic activation, the substance precipitated in soft agar. No evidence of the induction of point mutations by the test substance or by its metabolites formed as a result of microsomal activation was detectable in the strains of S. typhimurium used in these experiments.
Read across justification
Toxicity after repeated dose administration of the test item was not evaluated; reliable, experimental data of an analogue are available.
The substances share high similaritiy in structure and have comparable physico-chemical properties. Both substances are solids of poor water solubility and insoluble in most of the common organic solvents. The molecular weight of both compounds is higher than 600 g/mol. The molecules includes phthalimid-like structures and bear the potential to release chlorinated phthalimid after enzymatic or bacterial cleavage. Therefore, the analogue substance was choosen to examine genotoxicity.
At first, the analogue was assessed for its potential to induce chromosomal damage (clastogenicity) or spindle poison effects (aneugenic activity) in NMRI mice using the micronucleus test method. For this purpose, the test substance, suspended in corn oil, was administered once orally to male animals at dose levels of 500 mg/kg, 1 000 mg/kg and 2 000 mg/kg body weight in a volume of 10 mL/kg body weight in each case. The animals were sacrificed and the bone marrow of the two femora was prepared 24 and 48 hours after administration in the highest dose group of 2 000 mg/kg body weight and in the vehicle controls. 2 000 polychromatic erythrocytes were evaluated per animal and investigated for micronuclei. No relevant inhibition of erythropoiesis determined from the ratio of polychromatic to normochromatic erythrocytes was detected. According to the results of the present study, the single oral administration of the test substance did not lead to any relevant increase in the number of polychromatic erythrocytes containing either small or large micronuclei.
In the course of a second study, the analogue compound was assessed for its potential to induce DNA repair synthesis (unscheduled DNA synthesis; UDS) in hepatocytes of Wistar rats in vivo at 3-hour and 14-hour sampling time. For this purpose, the test substance, suspended in corn oil, was administered once orally to male animals at dose levels of 1 000 mg/kg and 2 000 mg/kg body weight in a volume of 10 mL/kg body weight in each case. The animals were anesthetized and the hepatocytes were harvested by in situ liver perfusion 3 and 14 hours after administration of the test substance. After an attachment period of at least 2 hours the cells were incubated for 4 hours with radiolabeled thymidine in vitro. After washing the hepatocytes were cultivated overnight until fixation. After autoradiography and hematoxylin-eosin-staining three animals per test group with at least 100 cells per animal were scored for DNA repair activity (incorporation of radiolabeled thymidine). No signs of toxicity were observed after administration of 1 000 mg/kg and 2 000 mg/kg body weight at both sacrifice intervals. No reduced viability of hepatocytes as indication for test substance induced toxicity was observed. The single oral administration of the test item did not lead to an increase in the mean net nuclear grain counts at any dose level at both sacrifice intervals.
Short description of key information:
The test item was evaluated in two Ames tests as well as in an UDS
and a micronucleus assay in vivo (according GLP and concurrent OECD
guideline). No mutagenicity was observed in the standard plate test or
in the prival preincubation test in the absence and the presence of
metabolic activatio. The substance did not induce unscheduled DNA
synthesis or micronuclei in vio.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance is not considered to be classified for genetic toxicity under Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.